METHYLENE BISACRYLAMIDE MARKET ANALYSIS
However, acrylamide is classified as an extremely hazardous substance in the U.S. The International Agency for Research on Cancer classifies acrylamide as a Group 2A carcinogen. Moreover, several substitutes are available for methylene bisacrylamide. These factors are expected to hinder growth of the market over the forecast period.
The increasing demand for stable copolymers and composites is expected offer lucrative growth opportunities for players in the market. Moreover, stability and versatility of methylene bisacrylamide in majority of polymerization reactions related to acrylonitrile is expected to increase its preference over other alternatives, thereby contributing to the market growth.
Methylene Bisacrylamide Market Report Snapshots
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients